Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up

被引：0

作者：

Shiu Ting Mak

Albert Chak-ming Wong

机构：

[1] Caritas Medical Centre,Department of Ophthalmology

[2] Union Hospital,Department of Ophthalmology

来源：

Graefe's Archive for Clinical and Experimental Ophthalmology | 2013年 / 251卷

关键词：

Bevacizumab; Retinal Pigment Epithelium; Photodynamic Therapy; Indocyanine Green; Polypoidal Choroidal Vasculopathy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：401 / 402

页数：1

共 50 条

[1] Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
Mak, Shiu Ting
Wong, Albert Chak-ming
[J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (01) : 401 - 402
[2] Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
Fernando Arevalo, J.
Espinoza, Juan V.
[J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (08) : 1159 - 1166
[3] Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
J. Fernando Arevalo
Juan V. Espinoza
[J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249
[4] Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy
J. Fernando Arevalo
Juan V. Espinoza
[J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 403 - 404
[5] Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy
Arevalo, J. Fernando
Espinoza, Juan V.
[J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (01) : 403 - 404
[6] Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy
Smretschnig, E.
Hagen, S.
Glittenberg, C.
Ristl, R.
Krebs, I.
Binder, S.
Ansari-Shahrezaei, S.
[J]. EYE, 2016, 30 (06) : 805 - 811
[7] Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy
E Smretschnig
S Hagen
C Glittenberg
R Ristl
I Krebs
S Binder
S Ansari-Shahrezaei
[J]. Eye, 2016, 30 : 805 - 811
[8] Combination Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor for Recalcitrant Chronic Central Serous Chorioretinopathy
Chon, Andrew T.
Asahi, Masumi George
Gallemore, Ron P.
Wallsh, Joshua
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[9] Photodynamic therapy for central serous chorioretinopathy with choroidal neovascularization on optical coherence tomography angiography combined with intravitreal anti-vascular endothelial growth factor therapy or alone
Sonoda, Nao
Araki, Takashi
Komuku, Yuki
Iwami, Hisashi
Gomi, Fumi
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
[10] Combined Half Dose Photodynamic Therapy with Verteporfin and Intravitreal Bevacizumab for Chronic Central Serous Chorioretinopathy
Coskun, Erol
Gurler, Bulent
Erbagci, Ibrahim
[J]. OPHTHALMOLOGICA, 2014, 232 : 56 - 56

← 1 2 3 4 5 →